top of page
Virtuvax News
New comment by UMC Utrecht on the SynGEM vaccine trial is a plea to consider the vaccine in an RSV c
A new publication in the American Journal of Respiratory and Critical Care Medicine, headed by senior author prof. Louis Bont of UMC...
Phase I clinical trial data of Mucosis intranasal vaccine against respiratory syncytial virus (RSV)
Today phase I clinical trial data of the Mucosis intranasal RSV F protein vaccine were published on-line. The vaccine was shown to be...
bottom of page